In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Nonalcoholic fatty liver disease (NAFLD) and its more severe form NASH are common liver diseases in industrialized countries. Diabetes, obesity, the metabolic syndrome and NAFLD all share common ...

1). The prevalence of NAFLD was 30.2% (29.8% NHW, 23.1% NHB, and 39.4% MA, P < 0.001 by race/ethnicity). The prevalence of ATP-III-defined MetS was 20.5% (20.9% NHW, 16.3% NHB, and 25.5% MA ...

Loneliness and social isolation have been linked to an elevated risk of non-alcoholic fatty liver disease (NAFLD), according ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

Allogenic haematopoietic stem cell transplantation (allo-HSCT) can induce bone marrow fibrosis regression in patients with myelofibrosis (MF) however, the effect on the skeleton is unclear.

“When you’re eating all these highly processed, high fat, high sugar foods, insulin goes into overdrive, which creates insulin resistance, then excess blood sugar, and then fatty liver ...

Here, the authors show that inactivation of LXR signaling leads to the rapid development of metabolic dysfunction-associated steatohepatitis (MASH).